A Study Of Augmented Reality Real-Time Guidance With In-situ Feedback

Overview

About this study

The purpose of this study is to evaluate the feasibility and safety of using the LUMENA guidance system during clinical procedures in patients undergoing CT-guided needle Placement for kidney, liver, lymph node, abdominal mass and lung ablation/biopsy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Provision of signed and dated informed consent form

  • Stated willingness to comply with all study procedures and availability for the duration of the study

  • Male or female, ages 18-90 years

  • Patient referred to Interventional Radiology for CT-guided needle placement for ablation/biopsy.

Exclusion Criteria:

  • Patients who are unable to give informed consent themselves or through their parents.

  • Patients that do not fit into the gantry of the CT scanner.

  • Patients who are sensitive to radiation exposure such as pregnant women.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 04/27/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

David Sella, M.D.

Contact us for the latest status

Contact information:

David Sella

9049531496

sella.david@mayo.edu

More information

Publications

Publications are currently not available